澳门葡京网赌游戏
澳门葡京赌博游戏是全球性的, 科学, 以患者为中心的制药业务, 致力于卓越的研究, 处方药的开发和商业化.
Our differentiated and growing portfolio of approved medicines, global reach and rich R&D pipeline give us confidence that we will continue to grow faster than the industry over the near and medium term.
澳门葡京网赌游戏(AstraZeneca)董事长米歇尔
战略概述
受到澳门葡京赌博游戏的价值观和科学的启发, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients, 社会, 地球和澳门葡京赌博游戏的股东.
澳门葡京赌博游戏的目标是到2030年推出至少15种新药. 2023年批准了3个.
2023年成就:
56
2023年成就:
$45.8bn
总营收
总收入增长3%(按净成本计算为6%),达到458.11亿美元. 总营收, excluding COVID-19 medicines, increased 13% (15% at CER) to $45,488 million.
澳门葡京赌博游戏对地球的承诺
Science-led climate action and investments in nature and biodiversity are vital to improving health outcomes and proactively managing our environmental impact.
短期目标:
在2015年的基础上,到2026年将第1类和第2类温室气体排放量绝对减少98%;
We are accelerating the delivery of net-zero healthcare and our progress towards net zero. 澳门葡京赌博游戏是第一批在范围1中设定净零目标的公司之一, 2 and 3 verified under the Science Based Targets initiative Net-Zero Corporate Standard.
2023年成就:
-67.6%
自2015年起减少第1类和第2类温室气体排放.
(2022: -59.减少3%).
短期目标:
Launch first next-generation respiratory inhalers with near-zero climate impact propellant from 2025.
We continued to focus on the next-generation propellant transition for pMDI products in our respiratory portfolio. They are strategically important to our business and a key product-related element of 零碳雄心.
2023年成就:
99%
Safe API discharges for AstraZeneca sites and 94% safe API discharges for globally managed first-tier supplier sites.
经营活动产生的现金流量净额
$10.3bn •
按实际汇率计算上升5%至103.45亿美元
(2022年:98.08亿美元)
报告每股收益
$3.84
报告每股收益增加至3美元.84
(2022: $2.12)
核心每股收益
$7.26 •
按实际汇率计算上涨9%至7美元.26
(按成本成本计算上涨15%)
(2022: $6.66)